Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14220) 14220
Book Chapter (422) 422
Newsletter (398) 398
Newspaper Article (102) 102
Magazine Article (73) 73
Book / eBook (56) 56
Reference (17) 17
Government Document (11) 11
Transcript (7) 7
Web Resource (6) 6
Trade Publication Article (4) 4
Dissertation (2) 2
Conference Proceeding (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (10756) 10756
humans (10519) 10519
life sciences & biomedicine (10234) 10234
male (5958) 5958
female (5330) 5330
biological and medical sciences (3991) 3991
central nervous system (3935) 3935
medical sciences (3808) 3808
animals (3445) 3445
adult (3419) 3419
neurosciences & neurology (3113) 3113
middle aged (2644) 2644
neurosciences (2346) 2346
pharmacology & pharmacy (2239) 2239
pharmacology. drug treatments (2039) 2039
neurology (1973) 1973
clinical neurology (1793) 1793
psychiatry (1765) 1765
adolescent (1745) 1745
aged (1743) 1743
nervous system (1721) 1721
child (1713) 1713
treatment outcome (1625) 1625
care and treatment (1550) 1550
research (1479) 1479
central nervous system agents (1448) 1448
analysis (1412) 1412
central nervous system stimulants - adverse effects (1282) 1282
health aspects (1273) 1273
drug therapy (1255) 1255
medicine & public health (1244) 1244
central nervous system depressants (1242) 1242
central nervous system stimulants - therapeutic use (1204) 1204
risk factors (1159) 1159
rats (1147) 1147
pediatrics (1126) 1126
psychology. psychoanalysis. psychiatry (1125) 1125
abridged index medicus (1075) 1075
oncology (1063) 1063
neuropharmacology (1054) 1054
psychopharmacology (1019) 1019
brain (1015) 1015
central nervous system - drug effects (987) 987
dose-response relationship, drug (970) 970
young adult (865) 865
drugs (855) 855
patients (843) 843
clinical trials (823) 823
attention deficit disorder with hyperactivity - drug therapy (815) 815
mice (815) 815
double-blind method (808) 808
child, preschool (800) 800
cancer (768) 768
toxicology (757) 757
time factors (741) 741
surgery (731) 731
retrospective studies (725) 725
chemotherapy (718) 718
medicine (712) 712
general & internal medicine (696) 696
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (676) 676
medical research (651) 651
complications and side effects (629) 629
pharmacology (616) 616
pain (603) 603
inflammation (599) 599
children (591) 591
medicine, general & internal (588) 588
psychopathology. psychiatry (588) 588
review (584) 584
anesthesia (583) 583
internal medicine (578) 578
magnetic resonance imaging (572) 572
central nervous system stimulants - administration & dosage (568) 568
dosage and administration (566) 566
disease models, animal (552) 552
rodents (544) 544
studies (544) 544
research article (536) 536
anesthesiology (529) 529
usage (525) 525
drug therapy, combination (521) 521
pregnancy (520) 520
immunology (505) 505
aged, 80 and over (502) 502
science & technology - other topics (501) 501
infectious diseases (496) 496
proteins (496) 496
social sciences (488) 488
prospective studies (483) 483
physiological aspects (479) 479
rats, sprague-dawley (478) 478
central nervous system stimulants - pharmacology (477) 477
fundamental and applied biological sciences. psychology (477) 477
central nervous system diseases - chemically induced (475) 475
infant (475) 475
toxicity (473) 473
diagnosis (470) 470
attention deficit hyperactivity disorder (469) 469
central nervous system diseases (469) 469
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (23) 23
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Online Resources - Online (8) 8
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
Robarts - Stacks (2) 2
Baycrest Hospital - Course Reserves (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Gerstein Science - Course Reserves (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Pharmacy (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Reference (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT Schools - Stacks (1) 1
Women's College Hospital - Pharmacy (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14977) 14977
German (120) 120
French (85) 85
Japanese (74) 74
Russian (35) 35
Spanish (30) 30
Italian (21) 21
Portuguese (16) 16
Polish (12) 12
Norwegian (11) 11
Chinese (9) 9
Dutch (9) 9
Danish (7) 7
Hungarian (5) 5
Turkish (5) 5
Finnish (4) 4
Hebrew (4) 4
Swedish (3) 3
Romanian (2) 2
Czech (1) 1
Greek (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
by Peters, Solange and Camidge, D. Ross and Shaw, Alice T and Gadgeel, Shirish and Ahn, Jin S and Kim, Dong-Wan and Ou, Sai-Hong I and Pérol, Maurice and Dziadziuszko, Rafal and Rosell, Rafael and Zeaiter, Ali and Mitry, Emmanuel and Golding, Sophie and Balas, Bogdana and Noe, Johannes and Morcos, Peter N and Mok, Tony and ALEX Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Ageing with HIV: medication use and risk for potential drug-drug interactions
by Marzolini, Catia and Back, David and Weber, Rainer and Furrer, Hansjakob and Cavassini, Matthias and Calmy, Alexandra and Vernazza, Pietro and Bernasconi, Enos and Khoo, Saye and Battegay, Manuel and Elzi, Luigia and Swiss HIV Cohort Study and Swiss HIV Cohort Study Members and on behalf of the Swiss HIV Cohort Study
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 9/2011, Volume 66, Issue 9, pp. 2107 - 2111
HIV/AIDS | Older patients | Drug-drug interactions | Polypharmacy | Cardiovascular drugs | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Central Nervous System Agents - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Hormones - therapeutic use | Methadone - therapeutic use | Male | Narcotics - therapeutic use | Hormones - adverse effects | Central Nervous System Agents - adverse effects | Narcotics - adverse effects | Socioeconomic Factors | Drug Interactions | Adult | Anti-HIV Agents - therapeutic use | Female | Substance Abuse, Intravenous - complications | Anti-HIV Agents - adverse effects | HIV Infections - virology | Substance-Related Disorders - complications | Cardiovascular Agents - therapeutic use | Drug Prescriptions - statistics & numerical data | Aging - physiology | Switzerland - epidemiology | Gastrointestinal Agents - therapeutic use | HIV Infections - complications | HIV Infections - drug therapy | Aged | Gastrointestinal Agents - adverse effects | Methadone - adverse effects | Cardiovascular Agents - adverse effects | Cohort Studies | Antiretroviral drugs | Comparative analysis | Human immunodeficiency virus--HIV | Risk assessment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Nervous system effects of antituberculosis therapy
by Kass, Joseph S and Shandera, Wayne X
CNS drugs, ISSN 1172-7047, 2010, Volume 24, Issue 8, pp. 655 - 667
Pyrazinamide, adverse reactions | Aminoglycosides, adverse reactions | Ethambutol, adverse reactions | Antituberculars, adverse reactions | Adverse-drug-reactions | Isoniazid, adverse reactions | Cycloserine, adverse reactions | Metronidazole, adverse reactions | Tuberculosis | Aminosalicylic-acid, adverse reactions | Ethionamide, adverse reactions | Thioacetazone, adverse reactions | Linezolid, adverse reactions | Meropenem, adverse reactions | Rifampicin, adverse reactions | Fluoroquinolones, adverse reactions | Capreomycin, adverse reactions | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Antitubercular Agents - adverse effects | Humans | Antitubercular Agents - pharmacology | Male | Animals | Mycobacterium tuberculosis | Tuberculosis - drug therapy | Central Nervous System - drug effects | Female | Nervous System Diseases - chemically induced | Antitubercular Agents - poisoning | Antitubercular Agents - therapeutic use | Peripheral Nervous System - drug effects | Index Medicus
Journal Article
Details down arrow
4. Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: Epidemiology, prevention and management
by Graham, Johnny and Coghill, David
CNS drugs, ISSN 1172-7047, 2008, Volume 22, Issue 3, pp. 213 - 237
Clonidine, adverse reactions | Attention deficit hyperactivity disorder, treatment | Atomoxetine, adverse reactions | Central nervous system stimulants, adverse reactions | Bupropion, adverse reactions | Alpha 2 adrenergic receptor agonists, adverse reactions | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Growth Disorders - chemically induced | Mental Disorders - epidemiology | Mental Disorders - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Growth Disorders - prevention & control | Mental Disorders - prevention & control | Clinical Trials as Topic | Attention Deficit Disorder with Hyperactivity - drug therapy | Antidepressive Agents - therapeutic use | Nervous System Diseases - epidemiology | Nervous System Diseases - prevention & control | Central Nervous System Stimulants - therapeutic use | Propylamines - therapeutic use | Central Nervous System Stimulants - adverse effects | Atomoxetine Hydrochloride | Growth Disorders - epidemiology | Cardiovascular Diseases - epidemiology | Nervous System Diseases - chemically induced | Cardiovascular Diseases - chemically induced | Antidepressive Agents - adverse effects | Propylamines - adverse effects | Anorexia | Hyperactivity | Complications | Attention deficit hyperactivity disorder | Clinical trials | FDA approval | Epidemiology | Cancer therapies | Carcinogenesis | Children & youth | Prescription drugs | Sleep disorders | Side effects | Stimulants | Insomnia | Cell cycle | Teenagers | Drug dosages | Seizures | Child & adolescent psychiatry | Index Medicus
Journal Article
Details down arrow
5. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma a randomized clinical trial
by Stupp, Roger and Taillibert, Sophie and Kanner, Andrew and Read, William and Steinberg, David M and Lhermitte, Benoit and Toms, Steven and Idbaih, Ahmed and Ahluwalia, Manmeet S and Fink, Karen and Di Meco, Francesco and Lieberman, Frank and Zhu, Jay-Jiguang and Stragliotto, Giuseppe and Tran, David D and Brem, Steven and Hottinger, Andreas F and Kirson, Eilon D and Lavy-Shahaf, Gitit and Weinberg, Uri and Kim, Chae-Yong and Paek, Sun-Ha and Nicholas, Garth and Burna, Jordi and Hirte, Hal and Weller, Michael and Palti, Yoram and Hegi, Monika E and Ram, Zvi
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dacarbazine - adverse effects | Follow-Up Studies | Dacarbazine - therapeutic use | Mitosis | Humans | Middle Aged | Male | Electric Stimulation Therapy | Chemoradiotherapy | Glioblastoma - radiotherapy | Glioblastoma - surgery | Antineoplastic Agents, Alkylating - therapeutic use | Disease-Free Survival | Dacarbazine - analogs & derivatives | Survival Analysis | Adult | Female | Aged | Maintenance Chemotherapy | Temozolomide | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Statistical analysis | Toxicity | Glioblastoma | Central nervous system | Clinical trials | Cell division | Nervous system | Maintenance | Patients | Survival | Chemotherapy | Scalp | Skin | Portable equipment | Electric fields | Tumors
Journal Article
Details down arrow
6. Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions
by Lund, Marie and Petersen, Tonny Studsgaard and Dalhoff, Kim Peder
Drugs (New York, N.Y.), ISSN 0012-6667, 05/2017, Volume 77, Issue 8, pp. 859 - 883
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Anti-Infective Agents - metabolism | Anti-Infective Agents - pharmacology | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Gastrointestinal Agents - administration & dosage | Antineoplastic Agents - administration & dosage | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Central Nervous System Agents - adverse effects | Antineoplastic Agents - metabolism | Drug Interactions | Antineoplastic Agents - adverse effects | Antineoplastic Agents - pharmacology | Cell Line | Anti-Infective Agents - adverse effects | Immunologic Factors - administration & dosage | Gastrointestinal Agents - pharmacology | Anti-Infective Agents - administration & dosage | Cytochrome P-450 CYP3A Inhibitors | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Cytochrome P-450 CYP3A - metabolism | Central Nervous System Agents - administration & dosage | Central Nervous System Agents - pharmacology | Central Nervous System Agents - metabolism | Gastrointestinal Agents - adverse effects | Immunologic Factors - adverse effects | Immunologic Factors - metabolism | Immunologic Factors - pharmacology | Gastrointestinal Agents - metabolism | Cytochrome | Health care | Drugs | Enzymes | Membranes | Excretion | Decision making | Organs | Substrate inhibition | Breast cancer | Glycoproteins | Metabolism | Substrates | Proteins | Side effects | Blood-brain barrier | Plasma membranes | Protein expression | Protein transport | P-Glycoprotein | Transporter | Inducers
Journal Article
Details down arrow
7. Full Text Goodman & Gilman's The pharmacological basis of therapeutics
by Goodman, Louis S. 1906-2000 (Louis Sanford) and Brunton, Laurence L and Chabner, Bruce and Knollmann, Björn C
2011, 12th ed., McGraw-Hill's AccessMedicine, ISBN 0071624422, 2047
Pharmacology | Pharmacological Phenomena | Therapeutics | Drug Therapy | Chemotherapy
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights